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Abstract
Purpose Chemosensory changes are frequently observed side
effects of cytotoxic treatment and have an impact on daily life
by altering food-related behaviour and daily practices. For
oesophagogastric cancer patients, these changes can be partic-
ularly important as they may have specific needs with regard
to eating, due to obstruction of the upper intestinal tract. The
purpose of this study was to gain insight into the impact of
chemosensory and food-related changes in oesophagogastric
cancer patients undergoing chemotherapy and how this may
influence the practical and social aspects of food-related be-
haviour of patients and their relatives.
Methods We used a qualitative interview approach with a
cross-sectional design using semi-structured interviews.
Template analysis was used to analyse patients’ experiences
with and the impact of chemosensory changes on daily life.
Thirteen advanced oesophagogastric cancer patients treated
with capecitabine and oxaliplatin were included by
convenience sampling, recruited from one academic hospital,
and interviewed at home or in the hospital.
Results There was a large variation in the impact of
chemosensory changes in oesophagogastric cancer (OGC) pa-
tients, though daily life was impacted substantially when
chemosensory and/or food-related changes were experienced.
Three main themes emerged from the interviews: altered food
preferences, practical constraints in daily life, and impact on
social functioning.
Conclusion Chemosensory and food-related changes signifi-
cantly influenced food preferences and had practical and so-
cial consequences in daily life of patients and their relatives.
Specific nutritional care for these patients should be directed
towards enhancing food enjoyment and should take the spe-
cific needs, related to the location of the tumour, into account.
Keywords Cancer . Chemotherapy . Taste . Smell . Food
preferences
Introduction
Taste and smell alterations are among the most common side
effects in cancer patients undergoing cytotoxic treatment
[1–3]. Studies have reported a prevalence of 45 to 84 % for
self-reported taste changes and 5 to 60 % for smell changes
among cancer patients undergoing chemotherapy [2]. These
changes can lead to a decreased appetite, liking and enjoyment
of food, food avoidance, altered food preferences, food aver-
sions, a reduction in food intake and eventually malnutrition
in cancer patients [1, 4–10]. These different alterations in taste
and smell may seriously impact patients’ daily life and quality
of life [11–13]. For instance, taste and smell changes can af-
fect daily living, change practical routines and may also have
an impact on social functioning related to cooking and rituals
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of eating, such as eating together with family and friends [11,
14, 15]. In order to support patients in the course of their anti-
cancer treatment, it is important to further explore these expe-
rienced chemosensory changes.
To date, most studies assessing chemosensory changes dur-
ing chemotherapy were executed in heterogeneous study pop-
ulations undergoing a variety of chemotherapeutic regimens
[2]. However, it has been suggested that the experience of
taste and smell changes may depend on specific cytotoxic
agents used [16]. Additionally, patients with certain cancer
types may experience specific difficulties with respect to eat-
ing. For instance, in patients with oesophagogastric cancer
(OGC), eating may be particularly complicated by obstruction
of the upper intestinal tract, potentially resulting in a poor
nutritional status [17]. Therefore, it is of specific interest to
study how patients and their families experience the interac-
tions of these complications with chemosensory alterations
resulting from cytotoxic treatment.
So far, no studies have focussed on the impact and conse-
quences of chemosensory changes within advanced OGC pa-
tients receiving chemotherapy. In order to improve supportive
care, in particular nutritional advice and management strate-
gies for OGC patients with chemosensory changes, a better
understanding of the experiences of patients is needed. Not
only the experience of chemosensory changes and dietary
itself are of interest but also the impact of these experiences
and the consequences of these changes in daily life.
In this study, we use a qualitative approach to explore the
impact of chemosensory and food-related changes in ad-
vanced oesophagogastric cancer patients undergoing chemo-
therapy with two specific cytotoxic agents, capecitabine and
oxaliplatin, and study how this influences the practical and




We adopted qualitative approach, applying template analysis
to describe and interpret the lived experience of patients in
order to get a deep understanding of these experiences at both
a general and individual level [18]. The study was exempt
from formal ethical approval by the institutional medical
ethics committee of the Academic Medical Centre
(W14_010).
Participants
We included a convenience sample of patients with OGC di-
agnosed in the Academic Medical Centre (AMC) in
Amsterdam, the Netherlands. The following inclusion criteria
were applied: patients with diagnosed oesophageal and stom-
ach cancer who had a metastatic or unresectable carcinoma at
the time of diagnosis with aWHO performance status of 0 to 2
[19], who were currently receiving palliative chemotherapy
with capecitabine (Xeloda®) and oxaliplatin (Eloxatin®)
(CAPOX) and had completed at least two cycles of chemo-
therapy. We considered convenience sampling to be adequate
for broadly exploring the experiences of chemosensory chang-
es following chemotherapy. Patients were not purposefully
selected on reporting an altered chemosensory perception.
Data collection
MK, a clinical dietician and MSc student Nutrition and Health
at the time of the study, carried out semi-structured interviews.
She had no prior relationship with the participants. Interviews
were held at home or in the hospital, following patients’ pref-
erence, and lasted approximately 15–60 min. In the hospital,
rooms could be private or shared with other patients. During
the interviews, patients were often accompanied by a close
relative or friend, who was allowed to participate in the con-
versation. The interview guide was developed based on key
topics from literature and investigators’ knowledge and expe-
riences from clinical practice and further adapted in the course
of the study. Interviews covered changes in taste and smell,
appetite, enjoyment of food, food preferences, practical and
social consequences, strategies to handle changes and the im-
pact of changes in smell, taste on daily life and the impact of
such changes upon diagnosis. Interviews were audio recorded.
Data analysis
Interviews were transcribed and coded according to the tem-
plate analysis as described by King [20]. Template analysis is
a thematic analysis where, to analyse the data, the researcher
identifies a number of codes or themes that summarize key
ideas, concepts, actions or experiences extracted from the in-
terviews by reading and re-reading the text. Codes are orga-
nized hierarchically with the highest level codes representing
broad themes in the data and lower-level codes representing
more narrow or specified themes in the data. When patients
did not experience any changes in chemosensory function,
interviews were not or only partly transcribed, although all
interviews were reviewed for the final template.
The first two interviews were coded for main themes by
MK, together with and YV, a PhD student in the field of
sensory science and eating behaviour and studies
chemosensory changes during chemotherapy in cancer pa-
tients. The template was further developed in discussion with
EH, an elderly care physician with specific expertise in qual-
itative research, who was working on separate transcripts. MK
and YV constructed the final template on the basis of detailed
re-reading of the full set of transcripts and discussed their
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interpretations with EH and HvL, a medical oncologist spe-
cialized in the treatment of OGC patients.
Results
Thirteen patients were interviewed for this study, of whom
demographic and diagnostic data are summarized in Table 1.
We defined nine themes, each divided into further sub-themes
(Table 2). Three main themes pertained strongly to the expe-
rience of patients and are fully described: altered food prefer-
ences, practical constraints in daily life and the meaning of
chemosensory and food-related changes for social life.
General findings
We found a large individual variation in the perceived degree
and impact of chemosensory changes and other side effects of
chemotherapy in patients. Patients who experienced mild or
few side effects mostly did not experience alterations in their
sense of smell or taste either. In contrast to other side effects of
chemotherapy, patients did not always mention changes in
taste and smell spontaneously. Nevertheless, these changes
were described as important or as having a substantial impact
on their daily lives. Some patients reported that their daily
lives were greatly impacted by chemosensory changes, while
others experienced the impact as less significant. Two ex-
tremes are mentioned; Sam, a patient with only minor
chemosensory complaints, said:
I do find them noticeable [changes in taste and smell],
but I think it’s more important to live than to hand in
some of the sensory stimuli. (Sam)
Charles, a patient with severe complaints, believes that
these chemosensory changes do not outweigh the benefits of
chemotherapy.
I would not do it again [chemotherapy] if I knew what I
know now. (…) Should I be severely ill for nine or ten
weeks for just a few months extension of my life?
(Charles)
Patients found it difficult to describe changes in taste and
smell perception as distinct features and referred to changes in
flavour as a whole or instead jointly ascribed these to changes
in taste perception. They were, however, perfectly able to
articulate what these changes entailed:
I used to love cheese, but if I eat cheese now, I cannot
taste it. I only taste the saltiness. I also used to love quark
with blueberries.(...) If you would close your eyes and
take a bite it just doesn’t taste the way that it used to do.
(Nicole)
Patients described changes in taste or smell in terms of
having a reduced enjoyment of food.
You just hope that it’s over soon, because you don’t
enjoy food whatsoever. You just eat because you have
to, but there is no pleasure in it. You just hope that it will
improve soon. (Jacob)
Altered food preferences
A variety of altered food preferences were experienced by
patients, which are expressed by a need for more or less in-
tense flavours, changed food choices and food aversions.
To compensate for altered chemosensory perception, some
patients described a need for more intense flavours, which was
reflected by addition of condiments, like sugar, seasonings
and salt or by choosing products with a distinctive flavour.
I recognised, that during the period that I started tasting
less, I used more salt and more products with strong
flavours. I had also figured to eat herring: besides a lot
of nutrients, it also has a strong flavour. (Abraham)
Altered chemosensory perception did not always result in a
preference for more intense stimuli; in contrast, some patients
described a need for less intense flavours, specifically for
spicy products.
I need to be a bit careful not to eat spicy foods. Last
Wednesday for instance, I made beans with a spicy curry
paste and I had to pay the bill all night. That was too
spicy, so I need to take into account not to use too much
spicy herbs. (Nicole)
Besides preferences for more or less intense flavours, pa-
tients sometimes needed to choose other types of food.
Chemotherapy induced an enhanced sensitivity to cold, par-
ticularly a few days after oxaliplatin infusion, which resulted
in a preference for warm foods, the need to wear gloves to get
food out of the refrigerator or an urge to put all foods in the
microwave before consumption.
Many patients talked about eating food that could easily
pass the oesophagus. Some patients needed to switch to liquid
foods, in order to combat weight loss and maintain sufficient
energy intake. Some specific dry foods, like bread and meat
were avoided, because it could not easily pass the oesophagus.
It should easily slide through, it should not be too dry
and it has to be tasteful. (Sam)
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Another way to swallow dry foods was to drink along with
food. ForWilford this was a way to force the food to go down.
If I do not manage to get the food down, I take a glass of
apple juice, and swallow the food along with the apple
juice just to get it inside. I just have to get it inside.
(Wilford)
Patients often complained about food aversions, which
were frequently related to aversive cooking aromas. These
aversions could be directed at specific foods, like meat, or
more general towards reduced enjoyment of eating.
If you cook vegetarian, or just normal, it has a certain
smell. (...) It gives a smell which I find really annoying
now. It causes me to lose my appetite before eating it
(Wilford)
Changed food preferences were a challenge for partners
and relatives, who had to take the altered food preferences into
account during shopping and cooking.
You make sure that when you cook a meal you know that
he likes it (...) I used to make him some oven baked fish,. ..
but as soon as it was time to eat he looked at his plate, took
two bites and said BThat’s enough, well you don’t have to
cook that for me anymore.^ (Charles’s wife)
Practical constraints in daily life
Patients encountered many practical constraints in daily life,
mostly because of obstruction of the oesophagus. These
Table 2 Template
1. Changes in taste
1.1. Reduced taste perception
1.2. Enhanced taste perception
1.3. Altered taste perception
1.4. Constant taste without the presence of food (phantom)
2. Changes in smell
2.1. Reduced odour perception
2.2. Enhanced odour perception




4. Nutritional advice (dietician)
4.1. Adding more fat to the diet/eating products that contain more fat
4.2. Eating more protein-rich foods
4.3. Eating more frequently
5. Altered food preferences
5.1. Need for a more intense flavour
5.1.1. Addition of condiments
5.1.2. Choose products with a more distinctive flavour
5.2. Need for a less intense flavour
5.2.1. Less addition of seasonings
5.3. Changed food choices
5.3.1. Favouring warm food
5.3.2. Taking into account patients’ food preferences
5.3.3. Food for easy passage oesophagus
5.3.3.1. Liquid and smooth food
5.3.3.2. Avoiding dry and grainy food
5.3.3.3. Drink while eating
5.4. Food aversions
5.4.1. Decreased enjoyment in eating food
5.4.1.1. Not liking anything anymore
5.4.1.2. Counting nutrients
5.4.2. Aversion to specific foods
5.4.2.1. Aversion towards fried food and hot meals
5.4.2.2. Aversion towards meat
6. Practical constraints in daily life
6.1. Not being able to eat/drink
6.1.1. Not being able to eat/drink cold products
6.2. Not being able to swallow the food
6.3. Planning meals and dinners
6.4. Adapting to what is still possible to eat
6.4.1. Liquid and smooth food
6.4.2. Avoiding dry and grainy food
6.4.3. Drink while eating
6.4.4. Trying different foods
6.4.5. Eating more frequently
6.4.6. Eating less (frequently)
6.4.7. Eating smaller portions
7. Social functioning in daily life
Table 2 (continued)
7.1. Eating (together) less sociable
7.1.1. Fewer dinners with family and friends
7.1.2. Planning of meals
7.2. Role of partners and family
7.2.1. Taking into account patients’ food preferences
7.2.2. Family is motivating (forcing?) patient to eat
7.2.3. Change of family roles
7.3. Decreased pleasure in eating
8. Significance of chemosensory changes upon diagnosis
8.1. Limited impact of chemosensory changes compared to
chemotherapy benefits
8.2. Major impact of chemosensory changes compared to
chemotherapy benefits
9. General side effects of chemotherapy
9.1. Food-related side effects
9.2. Other side effects
10. Changes over time
10.1. Exacerbation of side effects with increased number of
chemotherapy cycles
10.2. Higher intensity of side effects at start of chemotherapy
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pertained to not being able to eat, drink or swallow, conse-
quences for the planning of meals and dinners, and adapting to
what was still possible to eat.
For some patients the daily routine was changed, meals and
dinners were planned at different times of the day. For instance
for Chadd, the daily pattern was changed in order not to get
any gastric refluxes during the night.
I’ll eat as much as possible preferably in the early after-
noon, around 2 pm or so. Not in the evening around 5 or
6 pm. Because I’ve had some of these refluxes at night,
it was complete panic. (Chadd)
Not being able to swallow the foods made patients slow
down and take their time while consuming a meal and there-
fore taking much more time.
It seems as if the food does not pass that fast, as if it gets
stuck. You have to slow down your eating, take pauses
between bites. (Nicole)
Patients had to adapt to what was still possible to
eat, not only by choosing or avoiding specific types of
food as previously described but also by changing their
food pattern into eating smaller portions, eating less
frequently, or more frequently but in smaller portions.
I rather eat more frequent during the day and smaller
portions than once or twice a large meal. (Sam)
Social functioning in daily life
Changes in social functioning were presented in several
ways; patients felt restricted because eating was less
sociable, needed to be planned and was less pleasurable.
Furthermore, partners and family members played a role
in social functioning by adjusting themselves to the al-
tered food preferences which sometimes resulted in a
change of roles within the family.
Eating with family and friends was less sociable because it
was less spontaneous and needed to be planned. Furthermore,
patients sometimes avoided going out for dinner from a fear of
not having the appropriate choices on a menu, or a fear for
complaints during eating.
But if you would say: ‘let’s go out for dinner this week
with the four of us’, I would say: rather not, I’m not that
good accompany. (Nixon)
Partners played an important role in the social aspect of
eating. Relatives often tried to stimulate patients to eat, by
taking into account patients’ food preferences and ensuring
sufficient nutritional intake, which made mealtime less
spontaneous.
We try to do that [making decisions about dinner] to-
gether. Beforehand we think about meals for today or for
the rest of the week. And by doing so, she [wife] takes
care that it is not too dry and so on. (Sam)
Patients sometimes tried to force themselves to eat from a
feeling of guilt towards their partners because of their efforts
into making food tasty.
You are eating and think: I’ll stuff it inside, but for my
wife it’s not pleasant at all because she is trying to make
something out of it. I’ll stuff it inside, but actually for me
it didn’t have to, because it just doesn’t taste right.
(Jacob)
The social aspect of cooking and eating was also changed
by a switch of roles for patients and partners in the household.
A partner may take over grocery shopping and cooking, be-
cause a patient was not able to do it anymore, or to keep a
patient from losing appetite from cooking smells by cooking
him/herself.
Chemosensory changes influenced social aspects of eating
resulting in a decreased pleasure in eating, where the role of a
meal changed from something pleasurable into a compulsory
way to ingest enough nutrients.
Nowadays eating is a ‘necessary evil’. So I do think the
social aspect is noticeable. You are counting the protein
and nutrients and it feels like a mathematical exercise.
My wife is thinking about the meals we shall try this
time. It is a quest to find what is possible and what tastes
good and so on. Nutrition and taste have a whole new
impact in that way, it’s noticeable and not for the better.
(Sam)
Discussion
This s tudy provides ins ight on the impact of
chemosensory and food-related changes on the life’s
of oesophagogastric cancer patients undergoing pallia-
tive chemotherapy. We found a large individual varia-
tion in the intensity and impact of changes in taste or
smell perception among patients. When patients expe-
rienced chemosensory and/or food-related changes, this
did not only result in altered food preferences but also
had practical implications and meaningfully influenced
social life.
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In the current study, a relatively homogeneous group
was interviewed, undergoing the same cytotoxic treat-
ment, while other studies that examined chemosensory
changes mainly used heterogeneous groups with respect
to type of cancer and/or treatment [2]. We found that,
also in a specific, rather homogeneous group, the impact
and meaning of chemosensory changes greatly vary. The
experiences of chemosensory changes found in the cur-
rent study generally support existing literature on this
topic with respect to altered food preferences and
changed social aspects of eating. More specific for this
particular group of patients with OGC are the prefer-
ences and practical constraints regarding eating food
that would easily pass the oesophagus.
Food preferences were influenced by chemosensory chang-
es during chemotherapy in several ways. These are in concor-
dance with previous studies where a need for both more and
less intense flavours and food aversions to cooking aromas
were described [1, 2, 21]. Typical for oxaliplatin treatment
was the increased sensitivity to cold food, which resulted in
a preference for warm food [22].
Although it seems an obvious observation that the obstruc-
tion of the oesophagus has consequences for food preferences
and dietary patterns, there is actually little literature available
on the experiences of this phenomenon in this patient group.
Studies in OGC patients have mainly focussed on experiences
after surgery rather than during or after chemotherapy [23,
24]. To our knowledge, this is the first study specifically fo-
cussing on the experience with regard to eating in this patient
group.
Changes in social aspects of eating were reported as
burdensome and entailed several aspects of social func-
tioning. Similar to previous studies, mealtime acquired a
new meaning by becoming a forced way to ingest nu-
trients, rather than an enjoyable part of the day [22, 23,
25, 26]. Social consequences, like the inability to eat
with family and friends and altered family roles, have
been reported in previous studies among patients with
various cancer sites undergoing chemotherapy [11, 22].
However, changed social functioning may not be solely
due to chemosensory changes, as these social conse-
quences have been reported in studies in oesophageal
cancer patients that do not undergo chemotherapy, as
well [23, 25].
Oesophagogastric cancer patients are susceptible to
weight loss, which is associated with a reduced quality
of life and a poor prognosis of the disease [17]. The
current study shows that OGC patients undergoing che-
motherapy both have problems regarding chemosensory
changes and difficulties with obstruction of the oesoph-
agus, hence making nutritional advice more complex.
Nutritional advice for this patient group therefore should
be multidimensional and go beyond aiming for
sufficient protein and energy intake, mainly taking into
account the changed food preferences and practical con-
straints, and should aim towards enhancing the enjoy-
ment of food. Furthermore, care strategies should not
only be directed at the patient but should also take into
account the role that the partner and family play in a
household. Finally, health-care professionals should ex-
plicitly ask for chemosensory changes, as patients do
not always mention these side effects spontaneously.
Nevertheless, the results of our study show that these
changes can have a substantial impact on daily life and
therefore should not be disregarded in hospital practice.
Applying template analysis as a method to explore
the experiences of patients with OGC resulted in a rich
description of the impact of chemosensory changes and
altered food preferences on the daily life of patients and
their relatives. The inclusion of a small, homogenous
sample of study participants allowed for in-depth explo-
ration of the lived experience of having OGC and suf-
fering from chemosensory changes. We did not specifi-
cally select patients with previously reported taste or
smell alterations, which has been done mostly in previ-
ous qualitative studies investigating chemosensory
changes during chemotherapy [11, 22, 27], but instead
included also patients experiencing no or little changes
in their taste and smell perception, to gain insight into a
broad range of experiences. However, including only
patients from the Netherlands, where standard cytotoxic
treatment for oesophagogastric cancer patients only in-
cludes oxaliplatin and capecitabine, may limit the trans-
ferability of our results to other treatment regimens,
contexts or countries. In other cultures, pre-existing
food preferences may be different from those in the
Netherlands, including the addition of other spices of
the use of other ways to prepare food. Moreover,
food-related behaviours and the social rituals around
sharing food together may differ across cultures,
resulting in different practical or social consequences
of both the anatomical changes related to tumour
growth and the chemosensory changes following pallia-
tive chemotherapy. Future research thus should include
patients from different cultural backgrounds in different
contexts.
Conclusion
The present study shows that there was a large variation
in the impact of chemosensory and food-related changes
in OGC patients. These changes had a substantial im-
pact on food preferences and had various practical and
social consequences in the daily life of patients and
their relatives. Specific nutritional care for these patients
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should be directed towards higher food enjoyment and
take the specific complaints due to the location of the
tumour into account.
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